vorinostat has been researched along with Takotsubo Cardiomyopathy in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Takotsubo Cardiomyopathy: A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khurana, I | 1 |
| Maxwell, S | 1 |
| Royce, S | 1 |
| Mathiyalagan, P | 1 |
| Karagiannis, T | 1 |
| Mazarakis, N | 1 |
| Vongsvivut, J | 1 |
| K N, H | 1 |
| Okabe, J | 1 |
| Al-Hasani, K | 1 |
| Samuel, C | 1 |
| El-Osta, A | 1 |
1 other study available for vorinostat and Takotsubo Cardiomyopathy
| Article | Year |
|---|---|
SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis.
Topics: Acetylation; Animals; Disease Models, Animal; Epigenesis, Genetic; Mice; Takotsubo Cardiomyopathy; V | 2021 |